Velcade and platelet count decreased Patient Reports February 11, 2012

Velcade Side Effects Report #5458068-X
Velcade side effect was reported by a Physician from UNITED KINGDOM on June 11, 2007. Female patient, 71 years of age, weighting 140.2 lb, was diagnosed with waldenstrom's macroglobulinaemia and was treated with Velcade. After drug was administered, patient experienced the following side effects: haematocrit decreased, lymphocyte count decreased, neutropenia, platelet count decreased, red blood cell count decreased, white blood cell count decreased. Velcade dosage: 2.20 MG, IV BOLUS. During the same period patient was treated with RITUXIMAB, ACYCLOVIR, AMITRIPTYLINE, LEVOTHYROXINE, LANSOPRAZOLE. Patient recovered.

Velcade Side Effects Report #5093281-5
Velcade side effect was reported by a Physician from UNITED STATES on Aug 16, 2006. Male patient, 66 years of age, weighting 105.8 lb, was diagnosed with squamous cell carcinoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: abdominal pain , diarrhoea, hypotension, lung infection, neutropenia, platelet count decreased, pneumonia , tachycardia, vomiting. Velcade dosage: 1.30 MG/M2, IV BOLUS. During the same period patient was treated with IRINOTECAN. Patient was hospitalized. Patient died on 08/12/2006.

Velcade Side Effects Report #5592622-X
Velcade side effect was reported by a Physician from UNITED STATES on Jan 01, 2008. Male patient, 66 years of age, weighting 105.8 lb, was diagnosed with squamous cell carcinoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: abdominal pain , diarrhoea, hypotension, hypoxia, neutropenia, neutrophil count decreased, platelet count decreased, pneumonia , refusal of treatment by relative. Velcade dosage: 1.30 MG/M2, IV BOLUS. During the same period patient was treated with IRINOTECAN. Patient was hospitalized. Patient died on 08/12/2006.

Velcade Side Effects Report #5149036-6
Velcade side effect was reported by a Physician from UNITED STATES on Oct 27, 2006. Male patient, 81 years of age, weighting 187.4 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Velcade. After drug was administered, patient experienced the following side effects: cerebral ischaemia, cerebrovascular accident, hypercoagulation, platelet count decreased, pneumonia aspiration. Velcade dosage: 1.0 MG/M2, IV BOLUS. During the same period patient was treated with GEMCITABINE, TYLENOL, DARVOCET. Patient was hospitalized. Patient died on 06/19/2003.


Velcade Side Effects Report #5930458-8
Velcade side effect was reported by a Physician from UNITED STATES on Oct 11, 2008. Female patient, 53 years of age, weighting 122.4 lb, was diagnosed with pancreatic carcinoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: abdominal pain , ascites, bacterial infection , dizziness , hypoalbuminaemia, hypotension, nausea , platelet count decreased. Velcade dosage: 1.3 MG/M2, IV BOLUS. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5805206-2
Velcade side effect was reported by a Physician from UNITED STATES on June 26, 2008. Male patient, child 6 years of age, weighting 50.27 lb, was diagnosed with neuroblastoma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: bacillus infection, blood culture positive, haemoglobin decreased, platelet count decreased. Velcade dosage: 1.04 MG, INTRAVENOUS. During the same period patient was treated with IRINOTECAN, HEPARIN, OXYCODONE, POTASSIUM IODIDE, PRILOSEC, ZOFRAN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5812254-5
Velcade side effect was reported by a Physician from UNITED STATES on July 07, 2008. Male patient, child 6 years of age, weighting 50.27 lb, was diagnosed with neuroblastoma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: bacillus infection, blood culture positive, gastric infection, haemoglobin decreased, platelet count decreased. Velcade dosage: 1.04 MG, UNK, INTRAVENOUS. During the same period patient was treated with IRINOTECAN, HEPARIN, OXYCODONE, POTASSIUM IODIDE, PRILOSEC, ZOFRAN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5829707-6
Velcade side effect was reported by a Physician from UNITED STATES on July 18, 2008. Male patient, child 6 years of age, weighting 50.27 lb, was diagnosed with neuroblastoma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: bacillus infection, blood culture positive, catheter related infection, haemoglobin decreased, platelet count decreased. Velcade dosage: 1.04 MG, INTRAVENOUS. During the same period patient was treated with IRINOTECAN, HEPARIN, OXYCODONE, POTASSIUM IODIDE, PRILOSEC, ZOFRAN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4616564-9
Velcade side effect was reported by a Consumer or non-health professional from on Dec 03, 2004. Male patient, 85 years of age, weighting 170.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: diarrhoea, platelet count decreased. Velcade dosage: unknown. Patient recovered.


Velcade Side Effects Report #4693567-X
Velcade side effect was reported by a Consumer or non-health professional from on Mar 29, 2005. Male patient, 85 years of age, weighting 170.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: diarrhoea, neuropathy peripheral, platelet count decreased. Velcade dosage: 2.14-2.04 MG, 2/WEEK, INTRAVENOUS. During the same period patient was treated with KYTRIL, DEXAMETHASONE, ATROPINE. Patient recovered.

Velcade Side Effects Report #5698765-4
Velcade side effect was reported by a Physician from JAPAN on Mar 24, 2008. Female patient, 84 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: loss of consciousness, platelet count decreased. Velcade dosage: 1.3 MG/M2, INTRAVENOUS. Patient recovered.

Velcade Side Effects Report #5332906-3
Velcade side effect was reported by a Physician from JAPAN on May 08, 2007. Female patient, 83 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: ascites, hyponatraemia, liver disorder, nerve injury, neuropathy peripheral, oedema peripheral, platelet count decreased, pleural effusion, volvulus. Velcade dosage: unknown. During the same period patient was treated with DECADRON, SULFAMETHOXAZOLE, DIFLUCAN, MUCOSTA, POLYMYXIN B SULPHATE, OMEPRAL, MAGNESIUM OXIDE. Patient was hospitalized and became disabled. Patient recovered.

Velcade Side Effects Report #5387450-4
Velcade side effect was reported by a Physician from JAPAN on July 02, 2007. Female patient, 83 years of age, weighting 83.78 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: ascites, hyponatraemia, liver disorder, malignant neoplasm progression, multiple myeloma , nerve injury, neuropathy peripheral, platelet count decreased, pleural effusion. Velcade dosage: unknown. During the same period patient was treated with DECADRON, SULFAMETHOXAZOLE, DIFLUCAN, MUCOSTA, POLYMYXIN B SULPHATE, OMEPRAL, MAGNESIUM OXIDE. Patient was hospitalized and became disabled. Patient died on 05/27/2007.

Velcade Side Effects Report #4881254-4
Velcade side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 21, 2005. Female patient, 83 years of age, weighting 125.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: haemorrhage, hypoaesthesia, pain in extremity, platelet count decreased. Velcade dosage: unknown. Patient was hospitalized and became disabled. Patient recovered.


Velcade Side Effects Report #4992448-1
Velcade side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 10, 2006. Female patient, 83 years of age, weighting 125.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: haemorrhage, hypoaesthesia, pain in extremity, platelet count decreased. Velcade dosage: 1.20 MG/M2, INTRAVENOUS. Patient was hospitalized and became disabled. Patient recovered.

Velcade Side Effects Report #5912904-9
Velcade side effect was reported by a Physician from JAPAN on Sept 29, 2008. Male patient, 81 years of age, weighting 112.4 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood pressure decreased, haemorrhage subcutaneous, myalgia, platelet count decreased, pleural effusion, pneumonia staphylococcal, respiratory failure, urinary retention. Velcade dosage: 2 MG, INTRAVENOUS. During the same period patient was treated with EPADEL, URSO, GLYCYRON, NORVASC, PRAVASTATIN, ALESION, DECADRON, PREDONINE. Patient died on 09/03/2008.

Velcade Side Effects Report #6111471-7
Velcade side effect was reported by a Physician from JAPAN on Feb 25, 2009. Male patient, 81 years of age, weighting 114.6 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood pressure decreased, dysstasia, haemorrhage subcutaneous, muscular weakness, myalgia, platelet count decreased, pleural effusion, pneumonia . Velcade dosage: 2 MG, INTRAVENOUS. During the same period patient was treated with EPADEL, URSO, GLYCYRON, NORVASC, PRAVASTATIN, ALESION, DECADRON, PREDONINE. Patient died on 09/03/2008.

Velcade Side Effects Report #4771234-1
Velcade side effect was reported by a Health Professional from UNITED STATES on June 24, 2005. Female patient, 81 years of age, weighting 147.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: petechiae, platelet count decreased. Velcade dosage: 1.70 MG; 2.00 MG. During the same period patient was treated with LIPITOR, ATENOLOL, EVISTA, SYNTHROID, GLUCOPHAGE. Patient recovered.

Velcade Side Effects Report #4989184-4
Velcade side effect was reported by a Health Professional from UNITED STATES on Jan 11, 2006. Male patient, 81 years of age, weighting 188.1 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: fatigue, fluid retention, liver function test abnormal, nausea , neuropathy peripheral, oedema peripheral, platelet count decreased, weight increased. Velcade dosage: 1.30 MG/M2, 2/WEEK, INTRAVENOUS. During the same period patient was treated with DEMADEX, COUMADIN, INSULIN, DIGIXIN, MAGNESIUM, POTASSIUM, ZOLOFT, CARDIZEM. Patient recovered.


Velcade Side Effects Report #4976249-6
Velcade side effect was reported by a Physician from AUSTRIA on Apr 05, 2006. Male patient, 81 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood creatinine increased, febrile neutropenia, haemoglobin decreased, mucosal inflammation, platelet count decreased, protein total increased, red blood cell count decreased, white blood cell count decreased. Velcade dosage: 1.90 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, DOXORUBICIN. Patient died on 03/31/2006.

Velcade Side Effects Report #4998510-1
Velcade side effect was reported by a Physician from AUSTRIA on Apr 05, 2006. Male patient, 81 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood creatine increased, febrile neutropenia, haemoglobin decreased, mucosal inflammation, platelet count decreased, protein total increased, red blood cell count decreased, white blood cell count decreased. Velcade dosage: 1.90 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, DOXORUBICIN. Patient died on 03/31/2006.

Velcade Side Effects Report #5551274-5
Velcade side effect was reported by a Physician from JAPAN on Nov 26, 2007. Female patient, 80 years of age, weighting 74.96 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: cardiac failure, haemoglobin decreased, malignant neoplasm progression, multiple myeloma , platelet count decreased. Velcade dosage: 1.40 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, FOSAMAX, ALDACTONE, DIFLUCAN, TENORMIN, ASPIRIN, BAKTAR, PROTECADIN. Patient died on 10/24/2007.

Velcade Side Effects Report #4881260-X
Velcade side effect was reported by a Health Professional from UNITED STATES on Oct 27, 2005. Male patient, 80 years of age, weighting 196.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: platelet count decreased. Velcade dosage: 2.73 MG, IV BOLUS. Patient recovered.

Velcade Side Effects Report #5538437-X
Velcade side effect was reported by a Physician from JAPAN on Nov 26, 2007. Male patient, 79 years of age, weighting 130.1 lb, was diagnosed with multiple myeloma , constipation  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anorexia, asthma , constipation , cytomegalovirus infection , diarrhoea, hypokalaemia, neuropathy peripheral, platelet count decreased. Velcade dosage: 1.80 MG, INTRAVENOUS; 2.20 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, MAGNESIUM OXIDE, ALFAROL, KYTRIL, CLARITHROMYCIN, PRODIF, EXACIN. Patient was hospitalized. Patient recovered.


Velcade Side Effects Report #4842807-2
Velcade side effect was reported by a Physician from MEXICO on Oct 26, 2005. Male patient, 79 years of age, weighting 167.6 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: haemoglobin decreased, herpes zoster, intestinal obstruction, platelet count decreased. Velcade dosage: unknown. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5274577-0
Velcade side effect was reported by a Physician from BRAZIL on Mar 07, 2007. Male patient, 78 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: fall , haemorrhagic stroke, head injury, neuropathy, platelet count decreased, subdural haematoma. Velcade dosage: 1.00 MG/M2, INTRAVENOUS. Patient was hospitalized. Patient died.

Velcade Side Effects Report #5578226-3
Velcade side effect was reported by a Physician from JAPAN on Dec 10, 2007. Female patient, 78 years of age, weighting 116.8 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: cardiac failure, diarrhoea, disease progression, nausea , platelet count decreased, pulmonary oedema, pyrexia, treatment failure, white blood cell count decreased. Velcade dosage: 1.90MG, INTRAVENOUS; 1.70 MG, INTRAVENOUS; 1.30MG, INTRAVENOUS; 1.90MG, INTRAVENOUS. During the same period patient was treated with PREDNONINE, HYDROCORTISONE, WARFARIN, ACECOL, ENDOXAN. Patient was hospitalized. Patient died on 05/12/2007.

Velcade Side Effects Report #5584730-4
Velcade side effect was reported by a Physician from JAPAN on Dec 20, 2007. Female patient, 78 years of age, weighting 116.8 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: cardiac failure, diarrhoea, malignant neoplasm progression, multiple myeloma , nausea , oedema, platelet count decreased, pulmonary oedema, pyrexia. Velcade dosage: 1.90 MG, 1.70 MG , 1.30 MG, 1.90 MG INTRAVENOUS. During the same period patient was treated with PREDNISOLONE, HYDROCORTISONE, WARFARIN, ACECOL, ENDOXAN. Patient was hospitalized. Patient died on 05/12/2007.

Velcade Side Effects Report #5597975-4
Velcade side effect was reported by a Physician from JAPAN on Jan 07, 2008. Male patient, 78 years of age, weighting 156.5 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood creatinine increased, diarrhoea, oedema, platelet count decreased, pneumonia aspiration, pyrexia, rales, vomiting, white blood cell count decreased. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with GLYBURIDE, MARZULENE, METHYCOBAL, FAMOTIDINE, MAGNESIUM OXIDE, KINEDAK, PERINDOPRIL ERBUMINE, BASEN. Patient was hospitalized. Patient recovered.


Velcade Side Effects Report #5584730-4
Velcade side effect was reported by a Physician from JAPAN on Dec 20, 2007. Female patient, 78 years of age, weighting 116.8 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: cardiac failure, diarrhoea, malignant neoplasm progression, nausea , oedema, platelet count decreased, pulmonary oedema, pyrexia, white blood cell count decreased. Velcade dosage: 1.90 MG, 1.70 MG , 1.30 MG, 1.90 MG INTRAVENOUS. During the same period patient was treated with PREDNISOLONE, HYDROCORTISONE, WARFARIN, ACECOL, ENDOXAN. Patient was hospitalized. Patient died on 05/12/2007.

Velcade Side Effects Report #5719039-9
Velcade side effect was reported by a Physician from JAPAN on Apr 14, 2008. Female patient, 78 years of age, weighting 127.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, dysgeusia, headache , herpes zoster, lymphocyte count decreased, malaise, nausea , platelet count decreased, protein urine present. Velcade dosage: 2 MG, INTRAVENOUS. During the same period patient was treated with CONIEL, AMITRIPTYLINE, LENDORM, ZOLPIDEM TARTRATE, RESLIN, DEPAS, MAGNESIUM OXIDE, FAMOTIDINE. Patient died on 03/27/2008.

Velcade Side Effects Report #5730364-8
Velcade side effect was reported by a Physician from JAPAN on Apr 25, 2008. Male patient, 78 years of age, weighting 156.5 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood potassium increased, diarrhoea, hepatic function abnormal, platelet count decreased, pneumonia aspiration, renal failure, vomiting, white blood cell count decreased. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with GLYBURIDE, MARZULENE S, METHYOCOBAL, FAMOTIDINE, MAGNESIUM OXIDE, KINEDAK, PERINDOPRIL ERBUMINE, BASEN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5794652-1
Velcade side effect was reported by a Physician from JAPAN on June 17, 2008. Female patient, 78 years of age, weighting 127.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, dysgeusia, headache , herpes zoster, lymphocyte count decreased, malaise, nausea , platelet count decreased, protein urine present. Velcade dosage: 2 MG, INTRAVENOUS. During the same period patient was treated with CONIEL, AMITRIPTYLINE, LENDORM, ZOLPIDEM TARTRATE, RESLIN, DEPAS, MAGNESIUM OXIDE, FAMOTIDINE. Patient died on 03/27/2008.

Velcade Side Effects Report #6121960-7
Velcade side effect was reported by a Physician from UNITED STATES on Mar 04, 2009. Male patient, 78 years of age, weighting 168.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: demyelinating polyneuropathy, fall , platelet count decreased, urinary retention. Velcade dosage: 2.4 MG/M2. During the same period patient was treated with CECADRON, ZOFRAN. Patient was hospitalized and became disabled. Patient recovered.


Velcade Side Effects Report #4769843-9
Velcade side effect was reported by a Consumer or non-health professional from UNITED STATES on July 22, 2005. Female patient, 78 years of age, weighting 132.1 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: platelet count decreased. Velcade dosage: 2.00 MG INTRAVENOUS. During the same period patient was treated with INSULIN, FUROSEMIDE, AVALIDE, TIMOLOL MALEATE, ATENOLOL, FOSAMAX, NORVASC. Patient recovered.

Velcade Side Effects Report #5534371-X
Velcade side effect was reported by a Physician from JAPAN on Nov 20, 2007. Male patient, 77 years of age, weighting 119.0 lb, was diagnosed with multiple myeloma , prophylaxis, platelet count decreased and was treated with Velcade. After drug was administered, patient experienced the following side effects: constipation , erythema multiforme, hypotension, lymphopenia, platelet count decreased, viral infection . Velcade dosage: 2.00 MG, INTRAVENOUS. During the same period patient was treated with ACYCLOVIR, BAKTAR, PLATELETS, DEXAMETHASONE, ALLOPURINOL, ZANTAC, MUCOSTA, LASIX. Patient recovered.

Velcade Side Effects Report #5602195-0
Velcade side effect was reported by a Physician from JAPAN on Jan 10, 2008. Male patient, 77 years of age, weighting 119.0 lb, was diagnosed with multiple myeloma , prophylaxis, platelet count decreased and was treated with Velcade. After drug was administered, patient experienced the following side effects: constipation , erythema multiforme, hiccups, hypoaesthesia, hypotension, lymphopenia, platelet count decreased, upper respiratory tract inflammation, viral infection . Velcade dosage: 2.00 MG, INTRAVENOUS; 1.60 MG, INTRAVENOUS. During the same period patient was treated with ACYCLOVIR, BAKTAR, PLATELETS, DEXAMETHASONE, ALLOPURINOL, ZANTAC, MUCOSTA. Patient recovered.

Velcade Side Effects Report #5708421-1
Velcade side effect was reported by a Physician from JAPAN on Apr 03, 2008. Male patient, 77 years of age, weighting 134.5 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, platelet count decreased, pleural effusion, pneumonia , rash . Velcade dosage: 2.00 MG, INTRAVENOUS : 1.5 MG, INTRAVENOUS. During the same period patient was treated with ROCEPHIN, ALLOPURINOL, PURSENNID, AMLODIPINE BESYLATE, DIOVANE, ROHYPNOL. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5728567-1
Velcade side effect was reported by a Physician from JAPAN on Apr 21, 2008. Male patient, 77 years of age, weighting 134.5 lb, was diagnosed with multiple myeloma , pneumonia  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, laryngeal cancer, platelet count decreased, pleural effusion, pneumonia , pyrexia, rash , white blood cell count decreased. Velcade dosage: 2.00 MG, INTRAVENOUS; 1.5 MG, INTRAVENOUS. During the same period patient was treated with ROCEPHIN, ALLOPURINOL, PURSENNID, AMLODIPINE BESYLATE, DIOVANE, ROHYPNOL. Patient was hospitalized. Patient recovered.


Velcade Side Effects Report #4747757-8
Velcade side effect was reported by a Health Professional from FRANCE on July 19, 2005. Male patient, 77 years of age, weighting 99.21 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: grand mal convulsion, haemoglobin decreased, platelet count decreased. Velcade dosage: 1.43 MG, 2/WEEK, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4769862-2
Velcade side effect was reported by a Physician from UNITED STATES on July 29, 2005. Female patient, 77 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: platelet count decreased. Velcade dosage: unknown. Patient recovered.

Velcade Side Effects Report #4877902-5
Velcade side effect was reported by a Physician from TAIWAN, PROVINCE OF CHINA on Dec 26, 2005. Male patient, 77 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: acinetobacter infection, aneurysm , colon cancer, hyperkalaemia, klebsiella infection, metabolic acidosis, platelet count decreased, pneumonia , pyrexia. Velcade dosage: unknown. During the same period patient was treated with CEFTAZIDMINE PENTAHYDRATE, BETAMETHASONE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4911231-6
Velcade side effect was reported by a Physician from TAIWAN, PROVINCE OF CHINA on Jan 25, 2006. Male patient, 77 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: acinetobacter infection, aneurysm , disease recurrence, haemoglobin decreased, hyperkalaemia, klebsiella infection, metabolic acidosis, platelet count decreased, pneumonia . Velcade dosage: unknown. During the same period patient was treated with CEFTAZIDMINE PENTAHYDRATE, RUBDERIB. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4947505-2
Velcade side effect was reported by a Health Professional from AUSTRALIA on Feb 27, 2006. Male patient, 77 years of age, weighting 183.6 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: constipation , dysuria, lethargy, neutrophil count increased, orthostatic hypotension, platelet count decreased, pollakiuria, urinary tract infection . Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with CENTOLIN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4953920-3
Velcade side effect was reported by a Physician from UNITED STATES on Mar 06, 2006. Male patient, 77 years of age, weighting 224.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood calcium increased, cardiac arrest , cerebrovascular accident, dementia , platelet count decreased, renal failure, respiratory failure. Velcade dosage: unknown. Patient was hospitalized. Patient died on 03/06/2006.

Velcade Side Effects Report #5145388-1
Velcade side effect was reported by a Physician from KOREA, REPUBLIC OF on Oct 23, 2006. Female patient, 76 years of age, weighting 99.21 lb, was diagnosed with multiple myeloma , t-cell lymphoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: duodenal ulcer haemorrhage, haematocrit decreased, haemoglobin decreased, platelet count decreased. Velcade dosage: 1.75 + 1.35 MG, UNK, INTRAVENOUS. During the same period patient was treated with THALIDOMIDE, DEXAMETHASONE, ASTRIX. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5455168-5
Velcade side effect was reported by a Physician from JAPAN on Sept 04, 2007. Female patient, 76 years of age, weighting 108.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: asthma , platelet count decreased, pyrexia, rash , white blood cell count decreased. Velcade dosage: 1.74 MG, INTRAVENOUS. During the same period patient was treated with FAMOTIDINE, ALLOPURINOL, METHYCOBAL, INDACIN. Patient recovered.

Velcade Side Effects Report #5496905-3
Velcade side effect was reported by a Physician from JAPAN on Oct 18, 2007. Male patient, 76 years of age, weighting 108.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: heart rate decreased, hypoventilation, platelet count decreased, pneumonia bacterial, renal failure, respiratory failure, septic shock. Velcade dosage: 2.00 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, ALDACTONE, ALLOPURINOL, NEO LOTAN, LASIX, DIFLUCAN, ALBUMIN TANNATE. Patient died on 10/05/2007.

Velcade Side Effects Report #5552382-5
Velcade side effect was reported by a Physician from JAPAN on Nov 28, 2007. Female patient, 76 years of age, weighting 119.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, c-reactive protein increased, deep vein thrombosis , disease progression, neuropathy peripheral, neutrophil count decreased, platelet count decreased, pulmonary embolism , pyrexia. Velcade dosage: 1.90 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, DEXAMETHASONE PHOSPHATE, LASIX, PIPERACILLIN AND TAZOBACTAM, NORVASC, MUCOSTA, LANSOPRAZOLE, RIZE. Patient died on 10/29/2007.


Velcade Side Effects Report #5912908-6
Velcade side effect was reported by a Physician from JAPAN on Sept 24, 2008. Female patient, 76 years of age, weighting 108.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: asthma , blood amylase increased, c-reactive protein increased, disease progression, platelet count decreased, pyrexia, rash , white blood cell count decreased. Velcade dosage: 1.74 MG, INTRAVENOUS. During the same period patient was treated with FAMOTIDINE, ALLOPURINOL, METHYCOBAL, INDACIN, FLUTIDE INHALATION, SEREVENT. Patient died on 07/14/2008.

Velcade Side Effects Report #6068304-7
Velcade side effect was reported by a Physician from JAPAN on Jan 22, 2009. Female patient, 76 years of age, weighting 154.3 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: acute myocardial infarction, altered state of consciousness, cerebral infarction, herpes zoster, hypokalaemia, hyponatraemia, platelet count decreased, renal failure acute, respiratory arrest. Velcade dosage: 1.8 MG, INTRAVENOUS. During the same period patient was treated with DECADRON, LASIX, ETODOLAC, FENTANYL, OXYCONTIN, MEROPEN, MORPHINE. Patient died on 11/28/2008.

Velcade Side Effects Report #4666454-0
Velcade side effect was reported by a Health Professional from on May 02, 2005. Male patient, 76 years of age, weighting 208.8 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood disorder, blood pressure decreased, dizziness , haematocrit decreased, haemoglobin decreased, heart rate increased, platelet count decreased, thrombocytopenia. Velcade dosage: 2.80 MG. During the same period patient was treated with LEKOVIT CA, FOLIC ACID, COLACE, SENNA, VALTREX, OXYCODONE, PAXIL. Patient recovered.

Velcade Side Effects Report #4701039-9
Velcade side effect was reported by a Physician from on June 13, 2005. Male patient, 76 years of age, weighting 213.8 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: haemoglobin decreased, impetigo , platelet count decreased, pseudo lymphoma, white blood cell count decreased. Velcade dosage: 2.60 MG, INTRAVENOUS. During the same period patient was treated with SOFRASOLONE, FLUTICASONE. Patient recovered.

Velcade Side Effects Report #4824108-1
Velcade side effect was reported by a Physician from UNITED STATES on Oct 25, 2005. Female patient, 76 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: cellulitis , clostridium colitis, dehydration, immunosuppression, platelet count decreased. Velcade dosage: unknown. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4976247-2
Velcade side effect was reported by a Physician from UNITED KINGDOM on Mar 31, 2006. Female patient, 76 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: gastrointestinal haemorrhage, multiple myeloma , neoplasm recurrence, platelet count decreased. Velcade dosage: unknown. During the same period patient was treated with OMEPRAZOLE, LACTULOSE, SANDOCAL, CLODRONATE DI. Patient died on 02/22/2006.

Velcade Side Effects Report #5458045-9
Velcade side effect was reported by a Physician from JAPAN on Sept 05, 2007. Female patient, 75 years of age, weighting 97.00 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, hypoaesthesia, nausea , neutrophil count decreased, platelet count decreased, pyrexia. Velcade dosage: 1.66 MG, INTRAVENOUS; 1.28 MG, INTRAVENOUS. During the same period patient was treated with ACTONEL, METHYCOBAL, URALYT, KYTRIL. Patient recovered.

Velcade Side Effects Report #5480956-9
Velcade side effect was reported by a Physician from JAPAN on Sept 26, 2007. Female patient, 75 years of age, weighting 97.00 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, hypoaesthesia, nausea , neutrophil count decreased, platelet count decreased, pyrexia. Velcade dosage: 1.66 MG, INTRAVENOS, 1.28 MG, INTRAVENOUS. During the same period patient was treated with ACTONEL, METHYCOBAL, URALYT, KYTRIL. Patient recovered.

Velcade Side Effects Report #5626474-6
Velcade side effect was reported by a Physician from JAPAN on Jan 30, 2008. Male patient, 75 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: dyspnoea, hepatic function abnormal, interstitial lung disease, platelet count decreased, pneumonitis. Velcade dosage: 1.60 MG, INTRAVENOUS. During the same period patient was treated with LASIX, KYTRILL, NEOPHAGEN, SOLITA, FAMOTIDINE, BAKTAR, ALLOPURINOL, DECADRON. Patient died on 01/23/2008.

Velcade Side Effects Report #5633208-8
Velcade side effect was reported by a Physician from JAPAN on Feb 05, 2008. Male patient, 75 years of age, weighting 127.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anorexia, interstitial lung disease, neurogenic bladder, neuropathy peripheral, platelet count decreased, pleural effusion, syncope. Velcade dosage: 2.20 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, ALFAROL, PURSENNID, MAGNESIUM OXIDE, LANSOPRAZOLE, KYTRIL, POLYETHYLENE GLYCOL, LOPERAMIDE. Patient was hospitalized and became disabled. Patient recovered.


Velcade Side Effects Report #5642503-8
Velcade side effect was reported by a Physician from JAPAN on Feb 15, 2008. Male patient, 75 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: hepatic function abnormal, platelet count decreased, pneumonitis, respiratory failure. Velcade dosage: 1.60 MG, INTRAVENOUS. During the same period patient was treated with LASIX, KYTRIL, NEOPHAGEN, SOLITA, FAMOTIDINE, BAKTAR, ALLOPURINOL, DECADRON. Patient died on 01/23/2008.

Velcade Side Effects Report #5731135-9
Velcade side effect was reported by a Physician from JAPAN on Apr 23, 2008. Male patient, 75 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anxiety , economic problem, marasmus, platelet count decreased. Velcade dosage: 1 MG/M2, INTRAVENOUS. Patient died on 04/09/2008.

Velcade Side Effects Report #5776746-X
Velcade side effect was reported by a Physician from JAPAN on Apr 23, 2008. Male patient, 75 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anxiety , marasmus, platelet count decreased. Velcade dosage: 1 MG/M2, INTRAVENOUS. Patient died on 04/09/2008.

Velcade Side Effects Report #5804277-7
Velcade side effect was reported by a Physician from JAPAN on June 30, 2008. Male patient, 75 years of age, weighting 147.7 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: abdominal discomfort, diarrhoea, disease progression, neuropathy peripheral, platelet count decreased, pyrexia. Velcade dosage: 2.3 MG, INTRAVENOUS; 1.8 MG, INTRAVENOUS. During the same period patient was treated with MAGTECT, PURSENNID, LENDORM, MECOBALAMIN, NEUROTROPIN, MAGNESIUM OXIDE. Patient died on 05/16/2008.

Velcade Side Effects Report #5811338-5
Velcade side effect was reported by a Physician from JAPAN on July 03, 2008. Male patient, 75 years of age, weighting 147.7 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: disease progression, platelet count decreased. Velcade dosage: 2.3 MG, INTRAVENOUS; 1.8 MG, INTRAVENOUS. During the same period patient was treated with MAGTECT, PURSENNID, LENDORM, MECOBALAMIN, NEUROTROPIN, MAGNESIUM OXIDE. Patient died on 05/16/2008.

Velcade Side Effects Report #5930789-1
Velcade side effect was reported by a Physician from JAPAN on Oct 12, 2008. Female patient, 75 years of age, weighting 97.00 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: diplegia, disease progression, disorientation, dysstasia, leukoencephalopathy, paresis, platelet count decreased, pyrexia. Velcade dosage: 1.70 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, OXYCONTIN, ETODOLAC, RIZE, DOGMATYL, SULFAMETHOXAZOLE AND TRIMETHOPRIM, LENDORM, ZANTAC. Patient was hospitalized. Patient died on 03/18/2008.

Velcade Side Effects Report #5975031-0
Velcade side effect was reported by a Physician from JAPAN on Nov 20, 2008. Female patient, 75 years of age, weighting 114.6 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: haematotoxicity, peripheral sensorimotor neuropathy, platelet count decreased. Velcade dosage: 1.3 MG/M2, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, BAKTAR, LANSOPRAZOLE, MYCOCYST. Patient died on 11/01/2008.

Velcade Side Effects Report #5978734-7
Velcade side effect was reported by a Physician from JAPAN on Nov 20, 2008. Female patient, 75 years of age, weighting 108.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: constipation , diarrhoea, dry mouth, infection , nerve injury, platelet count decreased, upper respiratory tract inflammation. Velcade dosage: 1.2 MG , INTRAVENOUS; 1.7 MG , INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, ACYCLOVIR, RISEDRONATE, LOSARTAN POTASSIUM, MARZULENE S, JUVELA N. Patient died on 06/08/2008.

Velcade Side Effects Report #5989650-9
Velcade side effect was reported by a Physician from JAPAN on Nov 25, 2008. Female patient, 75 years of age, weighting 114.6 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: disease progression, haematotoxicity, movement disorder , nerve compression, oedema, peripheral sensorimotor neuropathy, plasmacytoma, platelet count decreased. Velcade dosage: 1.8 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, LANSOPRAZOLE, FLUCONAZOLE. Patient died on 11/05/2008.

Velcade Side Effects Report #6009121-3
Velcade side effect was reported by a Physician from JAPAN on Dec 04, 2008. Female patient, 75 years of age, weighting 97.00 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: diplegia, dysstasia, leukoencephalopathy, malignant neoplasm progression, paresis, platelet count decreased, pyrexia. Velcade dosage: 1.70MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, OXYCONTIN, ETODOLAC, RIZE, DOGMATYL, SULFAMETHOXAZOLE AND TRIMETHOPRIM, LENDORM, ZANTAC. Patient was hospitalized. Patient died on 03/18/2008.


Velcade Side Effects Report #6021679-7
Velcade side effect was reported by a Physician from JAPAN on Dec 09, 2008. Female patient, 75 years of age, weighting 114.6 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: amyloidosis, disease progression, haematotoxicity, peripheral sensorimotor neuropathy, platelet count decreased. Velcade dosage: 1.8 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, LANSOPRAZOLE, FLUCONAZOLE. Patient was hospitalized and became disabled. Patient died on 11/05/2008.

Velcade Side Effects Report #6140260-2
Velcade side effect was reported by a Physician from JAPAN on Mar 17, 2009. Female patient, 75 years of age, weighting 108.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: constipation , diarrhoea, dry mouth, nerve injury, platelet count decreased, sepsis , upper respiratory tract inflammation. Velcade dosage: 1.2 MG, INTRAVENOUS; 1.7 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, ACYCLOVIR, RISEDRONATE, LOSARTAN POTASSIUM, MARZULENE S, JUVELA N. Patient died on 06/08/2008.

Velcade Side Effects Report #4881340-9
Velcade side effect was reported by a Physician from UNITED STATES on Nov 03, 2005. Female patient, 75 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: platelet count decreased. Velcade dosage: unknown. During the same period patient was treated with LASIX, COZAAR, COUMADIN, TYLENOL ARTHRITIS, POTASSIUM. Patient recovered.

Velcade Side Effects Report #4992481-X
Velcade side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 08, 2005. Female patient, 75 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: neutrophil count decreased, platelet count decreased, white blood cell count decreased. Velcade dosage: 1.70 MG, INTRAVENOUS. Patient recovered.

Velcade Side Effects Report #5572347-7
Velcade side effect was reported by a Physician from JAPAN on Dec 14, 2007. Male patient, 74 years of age, weighting 108.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: disease progression, platelet count decreased, tumour lysis syndrome, varicella. Velcade dosage: 1.80 MG, INTRAVENOUS. During the same period patient was treated with PREDNISONE, ROHYPNOL, URINORM, NORVASC, METHYCOBAL, AMITRIPTYLINE, ITRACONAZOLE, BAKTAR. Patient was hospitalized. Patient died on 07/10/2007.

Velcade Side Effects Report #5989301-3
Velcade side effect was reported by a Physician from JAPAN on Nov 25, 2008. Female patient, 74 years of age, weighting 112.4 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, liver disorder, platelet count decreased. Velcade dosage: 1.8 MG, INTRAVENOUS. Patient recovered.

Velcade Side Effects Report #6023767-8
Velcade side effect was reported by a Physician from JAPAN on Dec 12, 2008. Female patient, 74 years of age, weighting 112.4 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, liver disorder, platelet count decreased. Velcade dosage: 1.8 MG, INTRAVENOUS. Patient recovered.

Velcade Side Effects Report #6050681-4
Velcade side effect was reported by a Physician from JAPAN on Jan 08, 2009. Female patient, 74 years of age, weighting 108.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, liver disorder, platelet count decreased. Velcade dosage: 1.8 MG, INTRAVENOUS. During the same period patient was treated with SUCRALFATE, LAC B, MAGNESIUM OXIDE, FAMOTIDINE, LOXONIN, ASPARA K, LEVOFLOXACIN. Patient recovered.

Velcade Side Effects Report #6131817-3
Velcade side effect was reported by a Physician from JAPAN on Mar 12, 2009. Male patient, 74 years of age, weighting 108.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: disease progression, platelet count decreased, tumour lysis syndrome, varicella. Velcade dosage: 1.80 MG, INTRAVENOUS. During the same period patient was treated with PREDNISOLONE, ROHYPNOL, URINORM, NORVASC, METHYCOBAL, AMITRIPTYLINE, ITRIZOLE, BAKTAR. Patient was hospitalized. Patient died on 07/10/2007.

Velcade Side Effects Report #5588249-6
Velcade side effect was reported by a Physician from JAPAN on Dec 28, 2007. Male patient, 73 years of age, weighting 158.7 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, bacterial infection , blood lactate dehydrogenase increased, lung disorder, platelet count decreased. Velcade dosage: 2.3 MG, INTRAVENOUS; 2.20 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE. Patient recovered.


Velcade Side Effects Report #5612811-5
Velcade side effect was reported by a Physician from JAPAN on Jan 24, 2008. Male patient, 73 years of age, weighting 138.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: constipation , disease progression, hypoaesthesia, platelet count decreased, rash . Velcade dosage: 2.00 MG, INTRAENOUS, 1.50 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, LOXOPROFEN, MUCOSTA, FLUCONAZOLE, BAKTAR, MAGNESIUM OXIDE, FAMOTIDINE. Patient died.

Velcade Side Effects Report #5622327-8
Velcade side effect was reported by a Physician from JAPAN on Jan 25, 2008. Male patient, 73 years of age, weighting 138.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: constipation , disease progression, hypoaesthesia, platelet count decreased, rash . Velcade dosage: 2.00 MG, INTRAVENOUS : 1.50 MG, INTRAVENOUS : 1.00 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, LOXOPROFEN, MUCOSTA, FLUCONAZOLE, BAKTAR, MAGNESIUM OXIDE. Patient died on 01/06/2008.

Velcade Side Effects Report #5703848-6
Velcade side effect was reported by a Physician from CHINA on Mar 25, 2008. Male patient, 73 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: haematemesis, haemoglobin decreased, haemoptysis, melaena, multi-organ failure, platelet count decreased. Velcade dosage: 2.20 MG, INTRAVENOUS. Patient died on 01/01/2008.

Velcade Side Effects Report #5714409-7
Velcade side effect was reported by a Physician from CHINA on Apr 08, 2008. Male patient, 73 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: haematemesis, haemoglobin decreased, haemoptysis, melaena, multi-organ failure, platelet count decreased. Velcade dosage: 2.20 MG, INTRAVENOUS. Patient died on 02/01/2008.

Velcade Side Effects Report #5719059-4
Velcade side effect was reported by a Physician from JAPAN on Apr 14, 2008. Male patient, 73 years of age, weighting 138.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: constipation , disease progression, hypoaesthesia, platelet count decreased, rash . Velcade dosage: 2.00 MG, INTRAVENOUS; 1.50 MG, INTRAVENOUS; 1.00 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, LOXOPROFEN, MUCOSTA, FLUCONAZOLE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, MAGNESIUM OXIDE. Patient died on 01/06/2008.

Velcade Side Effects Report #4564672-3
Velcade side effect was reported by a Physician from on Jan 11, 2005. Female patient, 73 years of age, weighting 123.5 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: agitation, arthralgia, confusional state, fall , haemoglobin decreased, insomnia, laboratory test abnormal, platelet count decreased, pneumonia . Velcade dosage: 2.10 MG, 3/WEEK, IV BOLUS. During the same period patient was treated with MOBLOC, MAGNESIUM, CALCIUM, VIGANTOLETTEN, PANTOZOL, HYDROCORTISON, VALORON RETARD, HEPARIN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4633331-0
Velcade side effect was reported by a Physician from on Mar 24, 2005. Male patient, 73 years of age, weighting 231.5 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood magnesium decreased, circulatory collapse, confusional state, decreased activity, neuropathy peripheral, paraesthesia, platelet count decreased, white blood cell count decreased. Velcade dosage: 3.00 MG, INTRAVENOUS; 2.30 MG, INTRAVENOUS. During the same period patient was treated with ALLOPURINOL, AMLODIPINE. Patient recovered.

Velcade Side Effects Report #4707638-2
Velcade side effect was reported by a Health Professional from FRANCE on June 16, 2005. Male patient, 73 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: chills, erythroblast count increased, haemoglobin decreased, platelet count decreased, serum ferritin increased, somnolence, white blood cell count decreased. Velcade dosage: 2.60 MG 2/WEEK INTRAVENOUS. During the same period patient was treated with FLECAINE, NOCTRAN, PREVISCAN, TENORMIN, NICARDIPINE, PAROXETINE HYDROCHLORIDE. Patient recovered.

Velcade Side Effects Report #5843041-X
Velcade side effect was reported by a Physician from JAPAN on July 29, 2008. Female patient, 72 years of age, weighting 108.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, cardiac failure congestive, cardiogenic shock, diarrhoea, hyperglycaemia, hypoaesthesia, platelet count decreased. Velcade dosage: 1.30 MG/M2 UNK INTRAVENOUS. During the same period patient was treated with DECADRON, RED BLOOD CELLS. Patient died on 03/21/2008.

Velcade Side Effects Report #4603113-4
Velcade side effect was reported by a Physician from on Feb 24, 2005. Female patient, 72 years of age, weighting 132.3 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: abscess limb, haemoglobin decreased, metastases to muscle, monarthritis, muscle necrosis, pain in extremity, platelet count decreased. Velcade dosage: 2.10 MG, INTRAVENOUS. During the same period patient was treated with HYDROMORPHONE, AMLODIPINE, ENALAPRIL MALEATE, PANTOPRAZOLE, SERTRALINE, TORSEMIDE, URAPIDIL. Patient recovered.

Velcade Side Effects Report #4814277-1
Velcade side effect was reported by a Physician from GERMANY on Oct 11, 2005. Female patient, 72 years of age, weighting 132.3 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: abscess limb, arthralgia, haemoglobin decreased, monarthritis, muscle abscess, muscle necrosis, pain in extremity, platelet count decreased. Velcade dosage: 2.10 MG, 2/WEEK, INTRAVENOUS. During the same period patient was treated with HYDROMORPHONE, AMLODIPINE, ENALAPRIL MALEATE, PANTOPRAZOLE, SERTRALINE, TORSEMIDE, URAPIDIL. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5246190-2
Velcade side effect was reported by a Physician from JAPAN on Feb 09, 2007. Female patient, 71 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, blood amylase increased, coagulation time prolonged, hepatic function abnormal, nausea , neuropathy peripheral, orthostatic hypotension, platelet count decreased, urinary retention. Velcade dosage: unknown. During the same period patient was treated with DEXAMETHASONE, PREDNISOLONE, LANSOPRAZOLE, BAKTAR, DEPAKENE, ROHYPNOL, MARZULENE S. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5261615-4
Velcade side effect was reported by a Physician from JAPAN on Feb 26, 2007. Female patient, 71 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, blood amylase increased, coagulation time prolonged, hepatic function abnormal, nausea , neuropathy peripheral, orthostatic hypotension, platelet count decreased, urinary retention. Velcade dosage: 1.70 MG, 1.30 MG/M2. During the same period patient was treated with DEXAMETHASONE, PREDNISOLONE, LANSOPRAZOLE, BAKTAR, DEPAKENE, ROHYPNOL, MARZULENE S. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5368126-6
Velcade side effect was reported by a Physician from JAPAN on June 06, 2007. Male patient, 71 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation , blood lactate dehydrogenase increased, c-reactive protein increased, diarrhoea, hypovolaemia, platelet count decreased, pleural effusion, pyrexia, rash . Velcade dosage: 2.20 MG,. During the same period patient was treated with PREDNISOLONE, ITRACONAZOLE, ALLOPURINOL, MUCOSTA, ZANTAC, BICARBONATE IN PLASTIC CONTAINER, ADOFEED, LOXONIN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5458047-2
Velcade side effect was reported by a Physician from JAPAN on Sept 05, 2007. Female patient, 71 years of age, weighting 121.3 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: folliculitis, hypotension, nasopharyngitis, neutrophil count decreased, oral herpes, platelet count decreased, pyrexia, toxic skin eruption, white blood cell count decreased. Velcade dosage: 2.00 MG, INTRAVENOUS. During the same period patient was treated with RANTIDINE HYDROCHLORIDE, REBAMIPIDE, PANTETHINE, MAGNESIUM OXIDE, PAROXETINE, AMOXICILLIN W, KAKKON. Patient recovered.

Velcade Side Effects Report #5466070-7
Velcade side effect was reported by a Physician from JAPAN on Sept 07, 2007. Male patient, 71 years of age, weighting 141.1 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation , blood lactate dehydrogenase increased, c-reactive protein increased, diarrhoea, disease progression, hypovolaemia, lymphocyte count decreased, platelet count decreased, pleural effusion. Velcade dosage: 2.20 MG, INTRAVENOUS. During the same period patient was treated with PREDNISOLONE, ITRACONAZOLE, ALLOPURINOL, MUCOSTA, ZANTAC, BICARBONATE IN PLASTIC CONTAINER, ADOFEED, LOXONIN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5485964-X
Velcade side effect was reported by a Physician from JAPAN on Oct 01, 2007. Male patient, 71 years of age, weighting 141.1 lb, was diagnosed with multiple myeloma , prophylaxis and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation , blood lactate dehydrogenase increased, c-reactive protein increased, diarrhoea, disease progression, hypovolaemia, lymphocyte count decreased, platelet count decreased, pleural effusion. Velcade dosage: 2.20 MG, INTRAVENOUS. During the same period patient was treated with BAKTAR, PREDNISOLONE, ITRACONAZOLE, ALLOPURINOL, MUCOSTA, ZANTAC, BICARBONATE IN PLASTIC CONTAINER, ADOFEED. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5634196-0
Velcade side effect was reported by a Physician from JAPAN on Feb 05, 2008. Female patient, 71 years of age, weighting 121.3 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, diarrhoea, left atrial dilatation, platelet count decreased, pleural effusion, pyrexia, rash , ventricular extrasystoles. Velcade dosage: 1.90 MG, INTRAVENOUS. During the same period patient was treated with ITRACONAZOLE, MAGNESIUM OXIDE, LENDORM, VALTREX, BIOFERMIN R, DIFLUCAN, MAXIPIME, LEVOFLOXACIN. Patient recovered.

Velcade Side Effects Report #5679631-7
Velcade side effect was reported by a Physician from JAPAN on Mar 12, 2008. Male patient, 71 years of age, weighting 141.1 lb, was diagnosed with multiple myeloma , prophylaxis and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation , blood lactate dehydrogenase increased, c-reactive protein increased, diarrhoea, disease progression, platelet count decreased, pleural effusion, pyrexia, rash . Velcade dosage: 2.20 MG, INTRAVENOUS. During the same period patient was treated with SULFAMETHOXAZOLE AND TRIMETHOPRIM, PREDNISOLONE, ITRACONAZOLE, ALLOPURINOL, MUCOSTA, ZANTAC, BICARBONATE IN PLASTIC CONTAINER, ADOFEED. Patient was hospitalized. Patient died on 08/23/2007.

Velcade Side Effects Report #5698787-3
Velcade side effect was reported by a Physician from JAPAN on Mar 24, 2008. Female patient, 71 years of age, weighting 121.3 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, cardiomegaly, diarrhoea, left atrial dilatation, platelet count decreased, pleural effusion, rash , ventricular extrasystoles. Velcade dosage: 1.9MG, INTRAVENOUS, 1.5 MG, INTRAVENOUS. During the same period patient was treated with ITRACONAZOLE, MAGNESIUM OXIDE, LENDORM, VALTREX, BIOFERMIN R, DIFLUCAN, MAXIPIME. Patient recovered.

Velcade Side Effects Report #6026227-3
Velcade side effect was reported by a Physician from JAPAN on Dec 15, 2008. Female patient, 71 years of age, weighting 121.3 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, cardiomegaly, diarrhoea, left atrial dilatation, pancytopenia, platelet count decreased, pyrexia, rash , ventricular extrasystoles. Velcade dosage: 1.9 MG, INTRAVENOUS ; 1.5 MG, INTRAVENOUS. During the same period patient was treated with ITRACONAZOLE, MAGNESIUM OXIDE, LENDORM, VALTREX, BIOFERMIN R, DIFLUCAN, MAXIPIME. Patient recovered.

Velcade Side Effects Report #6029384-8
Velcade side effect was reported by a Physician from JAPAN on Dec 25, 2008. Male patient, 71 years of age, weighting 125.7 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood urea increased, diarrhoea, gait disturbance, hypoaesthesia, hypokalaemia, platelet count decreased, renal failure. Velcade dosage: 2 MG, INTRAVENOUS; 1.5 MG, INTRAVENOUS. During the same period patient was treated with GLYBURIDE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4616675-8
Velcade side effect was reported by a Consumer or non-health professional from on Jan 27, 2005. Female patient, 71 years of age, weighting 170.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: nausea , platelet count decreased. Velcade dosage: unknown. During the same period patient was treated with ISOPTIN, ALLOPURINOL, AMITRIPTYLINE, OXYCONTIN, FUROSEMIDE. Patient recovered.

Velcade Side Effects Report #4778807-0
Velcade side effect was reported by a Physician from UNITED KINGDOM on Sept 09, 2005. Female patient, 71 years of age, weighting 191.8 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood potassium increased, haemoglobin decreased, hypertension, platelet count decreased, retinal vein occlusion, vision blurred. Velcade dosage: 1.96 MG, INTRAVENOUS. During the same period patient was treated with TRAMADOL, PAMIDRONATE DI, TEMAZEPAM. Patient recovered.

Velcade Side Effects Report #4903401-8
Velcade side effect was reported by a Physician from UNITED KINGDOM on Jan 20, 2006. Female patient, 71 years of age, weighting 191.8 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood potassium increased, bone lesion, disease progression, haemoglobin decreased, hypercalcaemia, hypertension, platelet count decreased, retinal vein occlusion, vision blurred. Velcade dosage: 1.96 MG, INTRAVENOUS. During the same period patient was treated with TRAMADOL, PAMIDRONATE DI, TEMAZEPAM. Patient died on 12/01/2005.

Velcade Side Effects Report #4998602-7
Velcade side effect was reported by a Physician from ITALY on Apr 28, 2006. Male patient, 71 years of age, weighting 160.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: contusion, disease progression, fall , heart rate increased, orthostatic hypotension, platelet count decreased, skin laceration, syncope. Velcade dosage: 2.30 MG, UNK; INTRAVENOUS ; 1.00 MG/M2, UNK; INTRAVENOUS. During the same period patient was treated with ZOLEDRONIC ACID. Patient was hospitalized. Patient recovered.